A major advantage of enGenes Biotech’s proprietary -eXpress™ proprietary technology platform for outstanding recombinant protein production in Escherichia coli (E.coli) is that it also facilitates the cloning and vector optimization required to ensure proteins that are free of antibiotic markers or antibiotic-resistant genes.
The enGenes-eXpress advanced growth decoupled mechanism allows customers to achieve customized solutions for the cost-effective production of antibiotic marker-free proteins in microbial expression systems.
For more information follow https://www.pharmaceutical-networking.com/antibiotic-resistance-marker-free-protein-production/
Comentarios